These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 27871026
1. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms? Demiralay C, Agorastos A, Yassouridis A, Jahn H, Wiedemann K, Kellner M. Psychoneuroendocrinology; 2017 Feb; 76():14-18. PubMed ID: 27871026 [Abstract] [Full Text] [Related]
2. Copeptin in CCK-4-induced panic in healthy man: Sexual dimorphisms in secretion pattern and panic response, but no correlation of copeptin with panic symptoms. Kellner M, Zwanzger P, Rupprecht R, Eser D, Yassouridis A, Wiedemann K. Psychoneuroendocrinology; 2019 Dec; 110():104433. PubMed ID: 31525566 [Abstract] [Full Text] [Related]
3. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Ströhle A, Holsboer F, Rupprecht R. Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152 [Abstract] [Full Text] [Related]
4. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone. Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K. World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662 [Abstract] [Full Text] [Related]
5. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks. Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K. Depress Anxiety; 2006 Oct; 23(3):139-44. PubMed ID: 16470820 [Abstract] [Full Text] [Related]
6. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Kellner M, Wiedemann K, Yassouridis A, Levengood R, Guo LS, Holsboer F, Yehuda R. Biol Psychiatry; 2000 Jan 15; 47(2):107-11. PubMed ID: 10664826 [Abstract] [Full Text] [Related]
7. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity. Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Blüher M, Kratzsch J, Then Bergh F. Psychoneuroendocrinology; 2017 Apr 15; 78():39-47. PubMed ID: 28167369 [Abstract] [Full Text] [Related]
8. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study. Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R. Neuropsychopharmacology; 2003 May 15; 28(5):979-84. PubMed ID: 12700707 [Abstract] [Full Text] [Related]
9. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4. Eser D, Leicht G, Baghai T, Pogarell O, Schüle C, Karch S, Nothdurfter C, Rupprecht R, Mulert C. J Psychiatr Res; 2009 Jan 15; 43(4):393-400. PubMed ID: 18534623 [Abstract] [Full Text] [Related]
10. Copeptin response to panic provocation with CO2 in healthy adults. Müller JC, Walter C, Leibold N, Wiedemann K, Kellner M, Demiralay C. J Psychiatr Res; 2023 Sep 15; 165():225-232. PubMed ID: 37517243 [Abstract] [Full Text] [Related]
11. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers. Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E. Neuropsychopharmacology; 2005 Jan 15; 30(1):192-5. PubMed ID: 15467707 [Abstract] [Full Text] [Related]
12. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Zwanzger P, Baghai TC, Schuele C, Ströhle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R. Neuropsychopharmacology; 2001 Nov 15; 25(5):699-703. PubMed ID: 11682253 [Abstract] [Full Text] [Related]
13. Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgieß J, Blüher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O. Stress; 2019 Jan 15; 22(1):93-102. PubMed ID: 30369292 [Abstract] [Full Text] [Related]
14. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers. McCann UD, Slate SO, Geraci M, Uhde TW. Anxiety; 2019 Jan 15; 1(6):258-67. PubMed ID: 9160584 [Abstract] [Full Text] [Related]
15. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4). Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F. Int J Neuropsychopharmacol; 2007 Apr 15; 10(2):285-9. PubMed ID: 16817979 [Abstract] [Full Text] [Related]
16. Copeptin as a marker of an altered CRH axis in pituitary disease. Lewandowski KC, Lewiński A, Skowrońska-Jóźwiak E, Malicka K, Horzelski W, Brabant G. Endocrine; 2017 Sep 15; 57(3):474-480. PubMed ID: 28795329 [Abstract] [Full Text] [Related]
17. The stress hormone copeptin: a new prognostic biomarker in acute illness. Katan M, Christ-Crain M. Swiss Med Wkly; 2010 Sep 15; 140():w13101. PubMed ID: 20872295 [Abstract] [Full Text] [Related]
18. Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results. Kellner M, Muhtz C, Stark K, Yassouridis A, Arlt J, Wiedemann K. Psychopharmacology (Berl); 2005 Apr 15; 179(1):310-5. PubMed ID: 15821951 [Abstract] [Full Text] [Related]
19. Neuropeptide S receptor gene variation modulates anterior cingulate cortex Glx levels during CCK-4 induced panic. Ruland T, Domschke K, Schütte V, Zavorotnyy M, Kugel H, Notzon S, Vennewald N, Ohrmann P, Arolt V, Pfleiderer B, Zwanzger P. Eur Neuropsychopharmacol; 2015 Oct 15; 25(10):1677-82. PubMed ID: 26235955 [Abstract] [Full Text] [Related]
20. Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects. Zwanzger P, Zavorotnyy M, Gencheva E, Diemer J, Kugel H, Heindel W, Ruland T, Ohrmann P, Arolt V, Domschke K, Pfleiderer B. Neuropsychopharmacology; 2013 Aug 15; 38(9):1648-54. PubMed ID: 23463151 [Abstract] [Full Text] [Related] Page: [Next] [New Search]